+36.1%
MRNA vs AMCR
+6.5%
+29.6%
-86.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | AMCR | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.4% | -1.6% | +7.0% | +6.6% |
| 7D | -1.1% | -6.3% | +5.2% | +3.9% |
| 30D | +126.1% | -7.8% | +133.9% | +142.6% |
| 3M | +190.0% | +7.5% | +182.5% | +188.2% |
| 6M | +157.2% | +2.7% | +154.5% | +160.2% |
| YTD | +388.2% | +6.0% | +382.2% | +377.5% |
| 1Y | +467.0% | +7.8% | +459.2% | +448.4% |
| 3Y | +36.1% | +5.8% | +30.3% | +25.3% |
| All | +36.1% | +6.5% | +29.6% | +25.3% |
Cumulative growth
Daily Returns
Daily percentage return beside AMCR.
Daily Out/Under-Performance
Portfolio return minus AMCR return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × AMCR return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded AMCR wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling